Characteristic of Clinical Studies on Baduanjin during 2000–2019: A Comprehensive Review

Table 1

Number of clinical studies on Baduanjin conducted in different countries/regions (n = 810).

Country/region	Study design (number of studies)					Total (%)
	SR	RCT	CCS	CS	CR
Chinese Mainland	35	603	66	82	3	789 (97.4)
Hong Kong	4	6	0	0	0	10 (1.2)
Taiwan	0	4	0	1	0	5 (0.6)
USA	1	0	0	0	0	1 (0.1)
Australia	1	0	0	0	0	1 (0.1)
Brazil	1	0	0	0	0	1 (0.1)
Chile	1	0	0	0	0	1 (0.1)
Spain	0	1	0	0	0	1 (0.1)
Macao	0	0	0	1	0	1 (0.1)

SR, systematic review; RCT, randomized clinical trial; CCS, nonrandomized controlled clinical studies (quasirandomized clinical trial or observational studies such as cohort or case-control studies); CS, case series; CR, case report; USA, United States of America.